AWP: Low Dose Atropine Study Discussion with Cheryl Chapman

episode

EyeCode Media not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

More from EyeCode Media

The Chris Wolfe Podcast:Your AMD Technology Isn’t the Problem—Your System Is 20 min · 21 Sep 2026

AWP: Beyond the Exam Room: Purpose, Myopia, and Population Health 54 min · 17 Sep 2026

The Chris Wolfe Podcast: The Power of Quality Supplements 48 min · 14 Sep 2026

The Chris Wolfe Podcast: All Things Caratenoids w/ Kirsten Ormsby 56 min · 18 May 2026

All episodes from EyeCode Media →

Report any issue

Source

Recorded16 Aug 2023

Publisherfeed.podbean.com ↗

Handlerec:9098036

Show notes

Dr. Cheryl Chapman joins to discuss the recent atropine study published in JAMA: "Low-Dose 0.01% Atropine Eye Drops vs Placebo for Myopia Control, A Randomized Clinical Trial" We also discuss best practices for improving patient communication and staff professional development including the Certified Myopia Manager Navigator certification for staff. Atropine is a great treatment option when managing children with myopia, and Dr. Cheryl Chapman discusses some of the studies, shares best practices and She has shared two different resources that she utilizes in her clinic and references during our discussion. Those can be found here: Expected Axial Length Progression by Age AAOMC Axial Length Graph Dr. Cheryl Chapman has instituted a full-scope myopia management clinic within her practice and works tirelessly to spread myopia management knowledge. In addition to working one-on-one with doctors to implement practice protocols, she lectures within the optometric community as well as to local pediatricians and ophthalmologists. She is also the current president of the American Academy of Orthokeratology and Myopia Control.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.